Pradaxa vs. Lovenox

See how Pradaxa and Lovenox compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Pradaxa is a twice-daily pill for long-term stroke and clot prevention, while Lovenox is an injectable typically used short-term around surgery, for acute clots, or with aspirin after a heart attack.

  • Both drugs carry a real bleeding risk, but Pradaxa's most common side effects are gastrointestinal, while Lovenox's most common issues are bruising and injection site reactions.

  • Pradaxa has a specific reversal drug for emergencies, while bleeding on Lovenox is typically managed with supportive care or protamine.

Pradaxa vs. Lovenox Drug Summary

Pradaxa

Pradaxa (dabigatran) is a direct thrombin inhibitor, a type of oral anticoagulant that lowers the risk of stroke in people with nonvalvular atrial fibrillation and treats or prevents recurrent DVT and PE. It comes as a capsule taken twice a day, with no routine blood monitoring required.

Lovenox

Lovenox (enoxaparin) is a low molecular weight heparin, an injectable anticoagulant used to prevent and treat DVT and PE and to reduce clot-related complications in certain heart attack patients. It's given as a subcutaneous injection, usually once or twice a day depending on the reason it's prescribed.

Pradaxa vs. Lovenox Side Effects

Pradaxa

Most common
Dyspepsia (up to 9%)
Vomiting (up to 8%)
Nausea (up to 5%)
Diarrhea (up to 5%)

Lovenox

Most common
Bleeding (up to 7%)
Anemia (up to 3%)
Ecchymosis (up to 3%)
Nausea (up to 3%)

Pradaxa vs. Lovenox Dosage

Pradaxa

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 150 mg twice daily At the start
Maximum dose 220 mg once daily Day 2 onward
Dose changes 3 increases Every day

Lovenox

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg/kg every 12 hours At the start
Maximum dose 40 mg once daily If needed
Dose changes 3 increases As tolerated

Pradaxa vs. Lovenox Indications

Pradaxa

Pradaxa is FDA-approved to reduce the risk of stroke and systemic embolism in people with nonvalvular atrial fibrillation. It also treats deep vein thrombosis (DVT) and pulmonary embolism (PE), helps prevent their recurrence, and is approved to prevent DVT and PE after hip replacement surgery.

  • Reduces stroke and systemic embolism risk in nonvalvular atrial fibrillation

  • Treats DVT and PE after 5 to 10 days of an injectable anticoagulant

  • Lowers the risk of DVT or PE happening again after initial treatment

  • Prevents DVT and PE after hip replacement surgery

  • Treats and helps prevent recurrent VTE in children age 8 and older

Lovenox

Lovenox is FDA-approved to prevent DVT after certain surgeries or during illness that limits mobility, and to treat existing DVT and PE. It's also used to reduce ischemic complications in unstable angina, non-Q-wave heart attacks, and STEMI heart attacks, usually together with aspirin.

  • Prevents DVT after hip or knee replacement, or abdominal surgery

  • Prevents DVT in patients with reduced mobility during acute illness

  • Treats DVT and PE, often without hospital admission

  • Reduces ischemic complications in unstable angina or NSTEMI, with aspirin

  • Treats acute STEMI heart attacks alongside aspirin and other therapy

Pradaxa vs. Lovenox Pros and Cons

Pradaxa

Pradaxa offers pill-based dosing without routine blood tests, but it still carries a real bleeding risk and needs a 5- to 10-day injectable overlap when starting DVT or PE treatment. Coverage and out-of-pocket costs for this brand-name DOAC vary widely by insurance plan.

Pros

  • Taken as a pill, with no injections needed for long-term use

  • No routine blood tests needed to monitor anticoagulation levels

  • Has a specific reversal agent (idarucizumab) for emergency bleeding or surgery

  • Approved for long-term stroke prevention in atrial fibrillation, not just clot treatment

Cons

  • Requires 5 to 10 days of injectable anticoagulant before starting DVT or PE treatment

  • Carries a higher rate of stomach-related side effects like dyspepsia than warfarin

  • Must be taken twice daily, on a strict, unforgiving schedule

  • Capsules can't be opened, crushed, or placed in a pill organizer

Lovenox

Lovenox is a well-established injectable anticoagulant with decades of surgical and cardiac use, but it requires self-injection rather than a daily pill. Coverage is often straightforward since generic enoxaparin is widely available and inexpensive.

Pros

  • Generic enoxaparin is widely available and well-established

  • Works right away without needing a loading dose first

  • Offers once-daily or twice-daily dosing depending on the indication

  • Long track record of safe use around surgery and during pregnancy

Cons

  • Requires self-injection, which many patients find inconvenient or uncomfortable

  • Injection site bruising, pain, and irritation are common side effects

  • Dose must be adjusted for severe kidney impairment and low body weight

  • Not approved for long-term stroke prevention in atrial fibrillation

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.